Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, June 23, 2022.
Teleflex’s voluntary recall of its Rüsch endotracheal tubes highlights the possibility of oxygen desaturation, and in the event, any immediate or long-term health consequences depend on the degree and duration of desaturation. Fast Five hosts Sean Whooley and Danielle Kirsh share what issue caused the recall and how many complaints the company has received so far.
The FDA’s IDE approval of Metavention’s renal denervation therapy represents an important milestone in the treatment of hypertension. Whooley details what the platform does, how it works and how optimistic executives are.
Real-world data validating the efficacy and usability of Bigfoot Biomedical’s diabetes management platform underscores its potential to revolutionize diabetes care. Kirsh and Whooley discuss some of the key data points from the study and the company’s future plans.
Insulet’s ongoing efforts to integrate its Omnipod 5 system with Abbott’s FreeStyle Libre 2 sensor marks a significant advancement in the company’s diabetes management technology. Whooley talks about where the technology is currently integrated and plans for a clinical study in the future.
The appointment of Lea Daniels Knight as CFO of Integra Lifesciences brings a seasoned financial leader to the company’s executive team. Hear about her prior experience in finance and medtech and what the company’s CEO has to say.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
